Application Information

This drug has been submitted to the FDA under the reference 202012/001.

Names and composition

"EPROSARTAN MESYLATE" is the commercial name of a drug composed of EPROSARTAN MESYLATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
202012/001 EPROSARTAN MESYLATE EPROSARTAN MESYLATE TABLET/ORAL EQ 400MG BASE
202012/002 EPROSARTAN MESYLATE EPROSARTAN MESYLATE TABLET/ORAL EQ 600MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
020738/004 TEVETEN EPROSARTAN MESYLATE TABLET/ORAL EQ 300MG BASE
020738/005 TEVETEN EPROSARTAN MESYLATE TABLET/ORAL EQ 400MG BASE
020738/006 TEVETEN EPROSARTAN MESYLATE TABLET/ORAL EQ 600MG BASE
202012/001 EPROSARTAN MESYLATE EPROSARTAN MESYLATE TABLET/ORAL EQ 400MG BASE
202012/002 EPROSARTAN MESYLATE EPROSARTAN MESYLATE TABLET/ORAL EQ 600MG BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved